Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Keppner-Witter

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Oncotarget|May 10, 2014
Combinatorial inhibition of Plk1 and PKCβ in cancer cells with different p53 statusLisa Lange, Sarah Keppner-Witter, Juline Grigat, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2014
Vanillin-derived antiproliferative compounds influence Plk1 activityRoberto Carrasco-Gomez, Sarah Keppner-Witter, Martina Hieke, et al.
Nature Medicine|June 26, 2026
Cliramitug for depletion of cardiac amyloid transthyretin: long-term follow-up of the NI006-101 trialPeter C Kahr, Fabian Aus dem Siepen, Olivier Lairez, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Oncotarget|May 10, 2014
Combinatorial inhibition of Plk1 and PKCβ in cancer cells with different p53 statusLisa Lange, Sarah Keppner-Witter, Juline Grigat, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2014
Vanillin-derived antiproliferative compounds influence Plk1 activityRoberto Carrasco-Gomez, Sarah Keppner-Witter, Martina Hieke, et al.
Nature Medicine|June 26, 2026
Cliramitug for depletion of cardiac amyloid transthyretin: long-term follow-up of the NI006-101 trialPeter C Kahr, Fabian Aus dem Siepen, Olivier Lairez, et al.
Pageof 1